Dermira Reports Third Quarter 2019 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Dermira (DERM) Tops Q3 EPS by 24c
November 5, 2019 5:15 PM ESTDermira (NASDAQ: DERM) reported Q3 EPS of ($1.06), $0.24 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $11.5 million versus the consensus estimate of $11.22 million.
The third quarter was marked by notable progress on key commercial, clinical and regulatory initiatives as we... More

